Kornitzer Capital Management Inc Halozyme Therapeutics, Inc. Transaction History
Kornitzer Capital Management Inc
- $5.1 Billion
- Q2 2024
A detailed history of Kornitzer Capital Management Inc transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 522,734 shares of HALO stock, worth $26.5 Million. This represents 0.54% of its overall portfolio holdings.
Number of Shares
522,734
Previous 485,234
7.73%
Holding current value
$26.5 Million
Previous $19.7 Million
38.66%
% of portfolio
0.54%
Previous 0.37%
Shares
16 transactions
Others Institutions Holding HALO
# of Institutions
504Shares Held
125MCall Options Held
208KPut Options Held
77.1K-
Black Rock Inc. New York, NY17.6MShares$892 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.9MShares$652 Million0.01% of portfolio
-
State Street Corp Boston, MA5.81MShares$294 Million0.01% of portfolio
-
Snyder Capital Management L P San Francisco, CA4.04MShares$205 Million4.92% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI3.72MShares$188 Million0.31% of portfolio
About HALOZYME THERAPEUTICS, INC.
- Ticker HALO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 139,288,992
- Market Cap $7.05B
- Description
- Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...